Nature Communications (Oct 2021)
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Abstract
Many African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by case counts.